The first-in-man clinical EVAR case using Lombard’s new IntelliFlex LP delivery system to deploy its Aorfix Endovascular Stent Graft has produced successful outcomes.
The British Society of Interventional Radiology (BSIR) took its campaign to improve the numbers of interventional radiologists in the NHS to Westminster, UK, in November, highlighting that this was a critical issue that needed significant Government focus.
The US FDA (Food and Drug Administration) has issued a safety communication concerning the separation of lubricious coatings from intravascular medical devices. The message aims to make healthcare providers aware of the possibility that hydrophilic and/or hydrophobic coatings may separate from medical devices and cause serious injuries to patients.
Spectranetics has reported that its peripheral atherectomy device—the Turbo-Power laser atherectomy catheter—has received US Food and Drug Administration (FDA) 510(k) clearance for the treatment of in-stent restenosis (ISR).
Two papers presented at the British Society of Interventional Radiology annual meeting (BSIR, 4–6 November, Glasgow, UK) highlighted that prostate artery embolization is a technically demanding procedure that is associated with prolonged radiation exposure to the patient and operator.
The transaction, consisting of an upfront payment of US$70 million and additional payments contingent on regulatory and sales milestones, will expand Boston Scientific’s interventional oncology portfolio with drug-eluting microspheres and spherical embolics.
Medtronic’s VenaSeal closure system has been granted pre-market approval (PMA) from the US Food and Drug Administration (FDA) for the treatment of symptomatic venous reflux.
Merit Medical, as part of its ThinkRadial programme, now offers, according to a press release, a new one-of-a-kind vascular training model at events throughout the world. The press release reports that the model is an example of the company’s commitment to provide in-demand, extensive radial training to further the advancement of physicians and their fields of medicine.
Renal Dynamics’ (ReDy) third-generation Renal Denervation System has been granted CE mark approval for the treatment of resistant hypertension and is now commercially available on the European market.
Toshiba announces the launch of the largest and most advanced commercially available mobile CT scanner in the UK. The new mobile imaging innovation already serves 12 CT imaging centres in the UK, travelling 3,500 miles per week from site-to-site.
Hansen has announced the completion of the world’s first clinical procedure using the Magellan Robotic Microcatheter Driver as part of the clinical study, “Embolization procedures in peripheral vasculature”.
Based on the success of its V-Probe variable ice cryoprobe which is used for prostate cryoablation procedures, Endocare has introduced a right angle version of the product. This modification allows the cryoprobe to be used in CT scanners and other limited access areas.
Endologix has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare.
Just weeks after 2015 country approval of Cook Medical’s Zenith Alpha abdominal endovascular graft, the University of Western London Health Sciences Centre in London, Ontario, has treated the first patient with the device as part of Cook’s Canada commercial launch.
Bayer and its development partner Janssen Pharmaceuticals presented results from two real world studies—the non-interventional XALIA study in patients with deep vein thrombosis (DVT) and a study looking at patients with cancer-associated thrombosis on 8 December 2015. Results from the two studies were presented at the 2015 ASH Annual Meeting, and XALIA findings were also simultaneously published in the Lancet Haematology.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos